Assignee
SERES THERAPEUTICS INC
US·26 granted patents·23 pending applications·433 citations·filing 2014–2025
Top patents by PatentIndex Score
49 records- 0199US10864235B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2018·Granted Dec 15, 2020·21 cites·18 claims
- 0298US9585921B2Compositions and methodsSERES THERAPEUTICS INC·Filed 2015·Granted Mar 7, 2017·49 cites·24 claims
- 0398US9446080B2Compositions and methodsSERES THERAPEUTICS INC·Filed 2016·Granted Sep 20, 2016·83 cites·30 claims
- 0498US9180147B2Compositions and methodsSERES THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·98 cites·24 claims
- 0597US9855303B2Compositions and methodsSERES THERAPEUTICS INC·Filed 2017·Granted Jan 2, 2018·28 cites·26 claims
- 0696US10967011B2Compositions and methodsSERES THERAPEUTICS INC·Filed 2018·Granted Apr 6, 2021·10 cites·18 claims
- 0796US10881696B2Network-based microbial compositions and methodsSERES THERAPEUTICS INC·Filed 2018·Granted Jan 5, 2021·10 cites·17 claims
- 0896US10064900B2Methods of populating a gastrointestinal tractSERES THERAPEUTICS INC·Filed 2014·Granted Sep 4, 2018·25 cites·17 claims
- 0996US10064901B2Compositions and methodsSERES THERAPEUTICS INC·Filed 2017·Granted Sep 4, 2018·21 cites·27 claims
- 1096US9956282B2Bacterial compositions and methods of use thereof for treatment of immune system disordersSERES THERAPEUTICS INC·Filed 2014·Granted May 1, 2018·10 cites·11 claims
- 1195US11730775B2Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereofSERES THERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·2 cites·32 claims
- 1295US11266699B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2018·Granted Mar 8, 2022·7 cites·20 claims
- 1395US11185562B2Compositions and methods for inhibition of pathogenic bacterial growthSERES THERAPEUTICS INC·Filed 2014·Granted Nov 30, 2021·12 cites·16 claims
- 1494US11464812B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·2 cites·20 claims
- 1594US10076546B2Network-based microbial compositions and methodsSERES THERAPEUTICS INC·Filed 2014·Granted Sep 18, 2018·23 cites·12 claims
- 1693US10973861B2Compositions and methodsSERES THERAPEUTICS INC·Filed 2014·Granted Apr 13, 2021·10 cites·19 claims
- 1793US10258655B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2014·Granted Apr 16, 2019·14 cites·14 claims
- 1892US11918612B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·1 cites·19 claims
- 1990US11389490B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2020·Granted Jul 19, 2022·1 cites·18 claims
- 2090US2025000915A1Methods of populating a gastrointestinal tractSERES THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2189US11458174B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2020·Granted Oct 4, 2022·1 cites·20 claims
- 2289US11458173B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2020·Granted Oct 4, 2022·1 cites·19 claims
- 2388US11666612B2Network-based microbial compositions and methodsSERES THERAPEUTICS INC·Filed 2021·Granted Jun 6, 2023·1 cites·22 claims
- 2487US12409197B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2024·Granted Sep 9, 2025·0 cites·20 claims
- 2582US2022249578A1Compositions and methods for inhibition of pathogenic bacterial growthSERES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2679US11701394B2Compositions and methods for treating cholestatic diseaseSERES THERAPEUTICS INC·Filed 2018·Granted Jul 18, 2023·2 cites·17 claims
- 2778US2024408151A1Compositions and methodsSERES THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2877US12083151B2Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2022·Granted Sep 10, 2024·0 cites·20 claims
- 2977US2025064869A1Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3070US2019192581A1Methods of Populating a Gastrointestinal TractSERES THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3170US2025017984A1Manipulation of tryptamine metabolismSERES THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3270US2021299191A1Compositions and methodsSERES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3369US2017165302A1Synergistic bacterial compositions and methods of production and use thereofSERES THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3467US12214002B2Compositions and methods for treating antibiotic resistanceSERES THERAPEUTICS INC·Filed 2018·Granted Feb 4, 2025·1 cites·20 claims
- 3567US2024216444A1Designed bacterial compositionsSERES THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3666US2024173367A1Compositions and methods for treating cholestatic diseaseSERES THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3766US2025288625A1Compositions and methods for treating antibiotic resistanceSERES THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3858US2021196766A1Designed bacterial compositions and uses thereofSERES THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3956US2025367242A1Designed bacterial compositions and uses thereofSERES THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4056US2020276249A1Manipulation of tryptamine metabolismSERES THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4152US2022017853A1Compositions for stabilizing bacteria and uses thereofSERES THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4251US2024000859A1Designed bacterial compositions for treating graft-versus-host-diseaseSERES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4349US2016040215A1Methods for Pathogen Detection and Enrichment from Materials and CompositionsSERES THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4446US2024148803A1Use of immunotherapy and microbiome modulation to treat cancerSERES THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4544US2023125810A1Designed bacterial compositions and uses thereofSERES THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4643US2019247447A1Designed bacterial compositionsSERES THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4743US2018200308A1Methods of treating colitisSERES THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4841US2021121505A1Compositions and methods for treating inflammatory bowel diseasesSERES THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4935US2021361721A1Treatment of a cancer by microbiome modulationSERES THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SERES THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →